Stocks have pulled back from their all-time highs this week as the U.S.-China trade war resolution may have run into more snags. Stocks were indicated to open higher on Friday, but the direction of the day seemed far from certain. Investors are starting to see upside targets issued for 2020, but many pressing issues and risks remain now that the bull market is over 10 and a half years old. This is a time for investors to consider what changes they should be making for their portfolios and assets heading into late 2019 and as 2020 approaches.
24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new ideas for traders and long-term investors alike. Some of the daily analyst calls cover stocks to buy, while others cover stocks to sell or to avoid.
We have provided these calls in a quick-hit summary for easy reading, and additional comments and trading data have been added on some of the calls. The consensus analyst price targets and other valuation metrics are from the Refinitiv sell-side research service.
These are the top analyst upgrades, downgrades and initiations for Thursday, November 21, 2019.
Baidu Inc. (NASDAQ: BIDU) was started as Neutral with a $134 target price (versus a $115.65 prior close) at Macquarie.
Baudax Bio (NASDAQ: BXRX) was started as Buy with a $12 target price (versus a $4.51 close) at Janney. The company was said to have Anjeso (IV meloxicam) heading toward the FDA finish line, with an approval likely in the first quarter of 2020.
Biohaven Pharmaceutical Holding Co. Ltd. (NASDAQ: BHVN) was started as Outperform with a $75 target price (versus a $52.70 close) at Wedbush Securities, with the firm talking up its views on its migraine treatment’s efficacy and also expanding the number of migraine patients treated with preventive therapies.
Celsius Holdings Inc. (NASDAQ: CELH) was named as the Bull of the Day at Zacks, which said that this low dollar stock is finding a lot of thirsty investors who are looking for growth. The shares most recently closed at $4.57, with a consensus price target of $10.00.
Cerner Corp. (NASDAQ: CERN) was started as Outperform with an $80 target price (versus a $68.47 close) at RBC Capital Markets.
Chuy’s Holdings Inc. (NASDAQ: CHUY) was raised to Outperform from Neutral and the price target was increased to $32 from $24.50 (versus a $26.73 close) at Wedbush.
Clean Harbors Inc. (NYSE: CLH) was started as Underperform with a $75 target price (versus an $84.66 close) at Jefferies.
Duke Energy Corp. (NYSE: DUK) was raised to Buy from Sell and the price target was raised to $93 from $88 (versus an $86.66 close) at Goldman Sachs. The consensus target price was $96.80 ahead of the call.
Hertz Global Holdings Inc. (NYSE: HTZ) was started as Hold with a $17 target price (versus a $15.37 close) at Jefferies.
H&R Block Inc. (NYSE: HRB) was started as Hold with a $28 target price (versus a $24.34 close) at Jefferies.
International Flavors & Fragrances Inc. (NYSE: IFF) was raised to Buy from Neutral and the target price was raised to $155 from $137 (versus a $136.88 close) at Citigroup.
JD.com Inc. (NASDAQ: JD) was started as Neutral with a $26 target price (versus a $32.17 close) at Macquarie.